Younger age of escalation of cardiovascular risk factors in Asian Indian subjects

  • Rajeev Gupta1Email author,

    Affiliated with

    • Anoop Misra2,

      Affiliated with

      • Naval K Vikram3,

        Affiliated with

        • Dimple Kondal3,

          Affiliated with

          • Shaon Sen Gupta3,

            Affiliated with

            • Aachu Agrawal5 and

              Affiliated with

              • RM Pandey4

                Affiliated with

                BMC Cardiovascular Disorders20099:28

                DOI: 10.1186/1471-2261-9-28

                Received: 05 January 2009

                Accepted: 05 July 2009

                Published: 05 July 2009

                Abstract

                Background

                Cardiovascular risk factors start early, track through the young age and manifest in middle age in most societies. We conducted epidemiological studies to determine prevalence and age-specific trends in cardiovascular risk factors among adolescent and young urban Asian Indians.

                Methods

                Population based epidemiological studies to identify cardiovascular risk factors were performed in North India in 1999–2002. We evaluated major risk factors-smoking or tobacco use, obesity, truncal obesity, hypertension, dysglycemia and dyslipidemia using pre-specified definitions in 2051 subjects (male 1009, female 1042) aged 15–39 years of age. Age-stratified analyses were performed and significance of trends determined using regression analyses for numerical variables and Χ2 test for trend for categorical variables. Logistic regression was used to identify univariate and multivariate odds ratios (OR) for correlation of age and risk factors.

                Results

                In males and females respectively, smoking or tobacco use was observed in 200 (11.8%) and 18 (1.4%), overweight or obesity (body mass index, BMI ≥ 25 kg/m2) in 12.4% and 14.3%, high waist-hip ratio, WHR (males > 0.9, females > 0.8) in 15% and 32.3%, hypertension in 5.6% and 3.1%, high LDL cholesterol (≥ 130 mg/dl) in 9.4% and 8.9%, low HDL cholesterol (<40 mg/dl males, <50 mg/dl females) in 16.2% and 49.7%, hypertriglyceridemia (≥ 150 mg/dl) in 9.7% and 6%, diabetes in 1.0% and 0.4% and the metabolic syndrome in 3.4% and 3.6%. Significantly increasing trends with age for indices of obesity (BMI, waist, WHR), glycemia (fasting glucose, metabolic syndrome) and lipids (cholesterol, LDL cholesterol, HDL cholesterol) were observed (p for trend < 0.01). At age 15–19 years the prevalence (%) of risk factors in males and females, respectively, was overweight/obesity in 7.6, 8.8; high WHR 4.9, 14.4; hypertension 2.3, 0.3; high LDL cholesterol 2.4, 3.2; high triglycerides 3.0, 3.2; low HDL cholesterol 8.0, 45.3; high total:HDL ratio 3.7, 4.7, diabetes 0.0 and metabolic syndrome in 0.0, 0.2 percent. At age groups 20–29 years in males and females, ORs were, for smoking 5.3, 1.0; obesity 1.6, 0.8; truncal obesity 4.5, 3.1; hypertension 2.6, 4.8; high LDL cholesterol 6.4, 1.8; high triglycerides 3.7, 0.9; low HDL cholesterol 2.4, 0.8; high total:HDL cholesterol 1.6, 1.0; diabetes 4.0, 1.0; and metabolic syndrome 37.7, 5.7 (p < 0.05 for some). At age 30–39, ORs were- smoking 16.0, 6.3; overweight 7.1, 11.3; truncal obesity 21.1, 17.2; hypertension 13.0, 64.0; high LDL cholesterol 27.4, 19.5; high triglycerides 24.2, 10.0; low HDL cholesterol 15.8, 14.1; high total:HDL cholesterol 37.9, 6.10; diabetes 50.7, 17.4; and metabolic syndrome 168.5, 146.2 (p < 0.01 for all parameters). Multivariate adjustment for BMI, waist size and WHR in men and women aged 30–39 years resulted in attenuation of ORs for hypertension and dyslipidemias.

                Conclusion

                Low prevalence of multiple cardiovascular risk factors (smoking, hypertension, dyslipidemias, diabetes and metabolic syndrome) in adolescents and rapid escalation of these risk factors by age of 30–39 years is noted in urban Asian Indians. Interventions should focus on these individuals.

                Background

                Cardiovascular diseases in developing countries are characterized by early age of onset and greater mortality [1]. Worldwide data reveal that while more than 70% of deaths in high income countries occur after the age of 70 years, in low and middle income countries more than 70 percent deaths occur below this age [2, 3]. Coronary heart disease occurs at least ten years earlier in South Asians as compared to other ethnic groups and the average age of stroke is much lower than in the western countries. The INTERHEART Study [4] reported that the mean age of myocardial infarction in South Asians was 52 years as compared to 60–65 years in European and North American cohorts. This study also reported that usual cardiovascular risk factors important in older subjects were equally important in the young South Asians [4].

                Cardiovascular risk factors have been studied in the younger populations-children, adolescents, and youth in different parts of the world [5]. These studies have been mainly confined to high income countries of North America, Europe and Australasia. Examples from USA include the Bogalusa Heart Study in Caucasians and Black Americans [6], National Health and Nutrition Examination Surveys (NHANES) [7], Muscatine Study [8], Coronary Artery Risk Development in Young Adults (CARDIA) study [9], Atherosclerosis Risk in Young Adults (ARYA) study [10], Atherosclerosis Risk Factors in Male Youngsters (ARMY) study [11], Pathobiological Determinants of Atherosclerosis in Young (PDAY) study [12], Minneapolis Children's Blood Pressure Study [13], and in Europe the Cardiovascular Risk in Young Finns study [14], North Ireland Young Heart Project [15] and many British studies [16]. All these studies have reported that the atherosclerosis factors start early in childhood and youth and the risk factors tend to track and magnify with age. The mean age at which the risk factors establish varies from 40–50 years [1719].

                Young subjects have not been well studied from low income countries. In India some studies have reported a moderate to high prevalence of multiple atherosclerosis risk factors in the adolescents and the young [20, 21]. Studies from metropolitan cities in non-governmental schools report a high prevalence of obesity [22]. In low-income schools in Indian urban and rural areas there is a low prevalence of obesity but high prevalence of smoking and tobacco use [23]. No studies that systematically evaluate these risk factors with age have been performed. Such studies are essential to develop cost-effective screening and intervention programs. We performed population based cross-sectional studies in two North Indian cities to study cardiovascular risk factors in the young subjects 15 to 39 years of age. The aims of the study were to determine prevalence of multiple cardiovascular risk factors in the adolescent and young adults and to study the age-group where risk factor determinants such as obesity and central obesity emerge and association of these with prevalence of high blood pressure, lipid abnormalities, diabetes, and metabolic syndrome.

                Methods

                To determine prevalence of various cardiovascular risk factors in adolescents and young adults, we performed population-based epidemiological studies in two north Indian cities, Jaipur and Delhi. The studies were approved by respective institutional ethics committees. These epidemiological population based studies were conducted between 1999 and 2002 in these cities by two investigators. One study was conducted in New Delhi that included subjects aged 14–25 years drawn from an approximate total population of 15,000 subjects from schools and colleges of southwest Delhi using multistage cluster sampling based on World Health Organization (WHO) Expanded Program of Immunization Sampling Plan as described elsewhere [24]. The data of subjects in age-group 15–25 years (n = 1680, 865 males, 815 females) were included for present analysis. The second study was conducted in the city of Jaipur in northwestern India using previously published methodology [25]. Total population of Jaipur in more than 23 million and the study was performed in six localities of Jaipur with population of 130,000 and 1123 subjects of the target 1800 (response 62.4%) were evaluated. In the present analysis, the data of subjects belonging to the age group 20–39 years (n = 371, 194 males, 177 females) were included. Informed consent was obtained from parents and school authorities in children ≤ 18 years of age and from all the adult subjects according to the ethics committee guidelines. History of previously diagnosed hypertension, diabetes or other diseases and smoking status or tobacco use in other forms was obtained.

                Height, weight, waist and hip circumferences measurements were recorded using previously reported methodology at each centre by a single centrally trained observer [24]. Blood pressure (BP) was recorded using a standard mercury sphygmomanometer with the subject seated and rested for five minutes. At least two readings at 5 minute interval were recorded and in case of an abnormal reading, another reading was obtained after 30 minutes. The data of anthropometric parameters (height, weight, waist size, and hip size) and blood pressure measurements were available for all subjects. Central training for technicians was performed to achieve uniformity in measurements and data collection. Height and weight were measured with calibrated instruments, waist was measured using a non-stretch steel tape measure at the mid-point of lower ribs and iliac crest in mid expiration in standing position and hip circumference was measured at inter-trochanteric level as reported earlier [24]. Fasting blood sample was obtained after an overnight fast for estimation of glucose, total cholesterol, high density lipoprotein (HDL) cholesterol and triglycerides using previously reported methodologies [24, 25]. Similar equipment and diagnostic reagents were used at both the centres to achieve standardization in biochemical measurements. Low density lipoprotein (LDL) cholesterol was calculated using Freidewald's formula.

                Definitions

                Cardiovascular risk factors studied were: smoking, obesity, high waist circumference (WC), hypertension, glucose intolerance, dyslipidemia (high LDL cholesterol, hypertriglyceridemia, low HDL cholesterol or high total-HDL cholesterol ratio). Overweight or obesity was defined as body mass index (BMI) ≥ 25 kg/m2. Among the measures of abdominal obesity, high WC was defined as >90 cm in males and >80 cm in females and high waist:hip ratio (WHR) was defined as >0.9 in males and >0.8 in females. Hypertension was defined as a persistent elevation of blood pressure ≥140/≥90 mm Hg or use of any anti-hypertensive medication. Impaired fasting glucose (IFG) was defined as fasting blood glucose value of ≥ 100 mg/dl and ≤125 mg/dl, and diabetes was defined as fasting blood glucose value ≥126 mg/dl or on any treatment. Dyslipidemias were defined according to the USA National Cholesterol Education Program (NCEP) criteria (high LDL cholesterol as ≥ 130 mg%, hypertyriglyceridemia as ≥ 150 mg/dl and low HDL cholesterol as <40 mg/dl in males and <50 mg/dl in females) [26]. High total cholesterol: HDL ratio was defined as >4.5. Metabolic syndrome was defined according to the NCEP definition with modified WC cut off values (males > 90 cm, females > 80 cm) [27].

                Statistical analysis

                For the purpose of analysis both the data sets were combined into one. Approximate normality was assessed for anthropometric and biochemical parameters. SPSS 10.0 and STATA 9.0 statistical softwares were used for data analyses. Quantitative characteristics were summarized by arithmetic mean and standard deviation. The differences in the anthropometric and biochemical parameters were compared using Z-test. Age-specific mean values of various anthropometric and biochemical characteristics were compared using one way ANOVA followed by post-hoc Bonferroni test. Anthropometric and biochemical characteristics were further categorized according to the cut off values as mentioned in the definition section. Categorical variables were summarized by percentages. Numerical trends in various cardiovascular risk factors across different age groups were assessed using regression analyses using CURVEFIT command of SPSS (version 10.0). Regression coefficients (B), standard deviations, standardized regression coefficients (beta), and p values were estimated. Χ 2 test for trend for performed for ordinal variables using the SPSS and are reported with p values. To determine the age associated escalation of risk factors odds ratios were calculated using logistic regression analysis. Univariate odds ratios (OR) and 95% confidence intervals (CI) were calculated with age-group 15–19 as baseline and compared with age-group 20–29 and 30–39 years. To determine significance of different measures of obesity (BMI, WC, WHR) multivariate logistic regression analyses were performed after adjustment for these factors. P value < 0.05 was considered statistically significant.

                Results

                Data of 2051 subjects aged 15–39 years (males 1009, females 1042) were evaluated in the present study. Subjects in different age groups were: 15–19 years 1292 (63.0%, 701 males and 591 females), 20–29 years 721 (20.5%, 174 males and 281 females), and 30–39 years 270 (6.0%, 59 males and 65 females). The prevalence of smoking was 6.6%, being higher in males (11.8%) than in females (1.4%). Various physical and biochemical characteristics of the study population are presented in Table 1. Mean BMI was similar in both males and females while WC, WHR and systolic and diastolic blood pressures were significantly higher in males as compared to females (p < 0.01). Mean fasting blood glucose was higher in males as compared to females (p < 0.01). The mean levels of total cholesterol, HDL cholesterol and LDL cholesterol were significantly higher in females (p < 0.01) whereas triglycerides levels were higher in males (p < 0.05). Obesity (BMI ≥ 25 kg/m2) was present in 13.4% (males 12.4%, females 14.3%), high WC in 13.3% (males 11.9%, females 14.7%), high WHR in 21.2% (males 13.7%, females 28.4%) and hypertension in 4.3% (males 5.6%, females 3.1%) subjects. Diabetes (known or diagnosed) was present in very small proportion (0.7%) of subjects, but impaired fasting glucose (100–125 mg/dl) was present in 10.8% (13.4% males, 8.2% females). Among the dyslipidemias, hypercholesterolemia was present in 7.9% (8% males, 7.8% females), high LDL cholesterol (≥ 130 mg/dl) in 9% (9.2% males, 8.7% females), hypertriglyceridemia in 7.9% (9.7% males, 6% females), low HDL cholesterol in 33.2% (16.2% males, 49.7% females) and high total:HDL cholesterol ratio in 13.5% (14.3% males, 12.7% females) subjects (Table 1).
                Table 1

                Physical and Biochemical Characteristics in the Study Subjects

                Variables

                Males (n = 1009)

                Females (n = 1042)

                Overall (n = 2051)

                Weight (kg)

                57.8 ± 13.2

                50.4 ± 10.1*

                54.0 ± 12.3

                Body mass index (kg/m2)

                20.6 ± 4.1

                20.7 ± 3.9

                20.7 ± 4.0

                Obesity (BMI kg/m2)

                   

                   23.0–24.9

                108 (10.7)

                94 (9.0)

                202 (9.8)

                   25.0–29.9

                93 (9.2)

                114 (10.9)

                207 (10.1)

                   ≥ 30

                32 (3.2)

                35 (3.4)

                67 (3.3)

                Waist (cm)

                74.4 ± 12.1

                70.0 ± 10.4*

                72.2 ± 11.5

                Waist size (cm)

                   

                   70–79

                284 (28.1)

                281 (27.0)

                565 (27.5)

                   80–89

                153 (15.2)

                102 (9.8)

                255 (12.4)

                   90–99

                79 (7.8)

                45 (4.3)

                124 (6.0)

                   ≥ 100

                45 (4.5)

                16 (1.5)

                61 (3.0)

                Waist:hip ratio

                0.83 ± 0.06

                0.77 ± 0.07*

                0.80 ± 0.07

                Waist:hip ratio

                   

                   0.70–0.799

                289 (28.6)

                581 (55.6)

                870 (42.4)

                   0.80–0.899

                567 (56.2)

                295 (28.3)

                862 (42.0)

                   0.90–0.999

                130 (12.9)

                39 (3.7)

                169 (8.2)

                   ≥ 1.00

                21 (2.1)

                3 (0.3)

                24 (1.2)

                Systolic BP (mm Hg)

                115.9 ± 10.9

                111.3 ± 10.7*

                113.6 ± 11.0

                Diastolic BP (mm Hg)

                74.9 ± 8.2

                73.2 ± 7.7*

                74.0 ± 8.0

                Hypertension (≥ 140/90 or known)

                57 (5.6)

                32 (3.1)*

                89 (4.3)

                Fasting glucose (mg/dl)

                89.9 ± 13.9

                88.3 ± 10.9*

                89.1 ± 12.5

                Glucose fasting (mg/dl)

                   

                   90–99

                370 (36.7)

                379 (36.4)

                49 (36.5)

                   100–109

                119 (11.8)

                81 (7.8)

                200 (9.8)

                   110–125

                16 (1.6)

                4 (0.4)

                20 (1.0)

                Diabetes (>125 mg/dl or known)

                10 (1.0)

                4 (0.4)

                14 (0.7)

                Cholesterol (mg/dl)

                153.5 ± 37.6

                162.7 ± 29.7*

                158.7 ± 49.7

                LDL cholesterol (mg/dl)

                87.1 ± 34.7

                93.2 ± 30.3*

                90.2 ± 32.7

                High LDL cholesterol (mg/dl)

                   

                   100–129

                214 (21.2)

                297 (28.5)

                511 (24.9)

                   130–159

                56 (5.6)

                62 (6.0)

                118 (5.7)

                   ≥ 160

                38 (3.8)

                30 (2.9)

                68 (3.3)

                Triglycerides (mg/dl)

                102.0 ± 58.2

                97.4 ± 40.3**

                99.7 ± 50.0

                High triglycerides (mg/dl)

                   

                   150–199

                58 (5.7)

                40 (3.8)

                98 (4.8)

                   200–399

                35 (3.5)

                22 (2.1)

                57 (2.8)

                   ≥ 400

                5 (0.5)

                1 (0.1)

                6 (0.3)

                HDL cholesterol (mg/dl)

                46.1 ± 7.85

                49.9 ± 9.79*

                48.05 ± 9.09

                Low HDL cholesterol (males < 40 mg/dl and females < 50 mg/dl)

                163 (16.2)

                518 (49.7)*

                681 (33.2)

                Total: HDL cholesterol

                3.48 ± 1.37

                3.43 ± 1.18

                3.45 ± 1.27

                High total: HDL cholesterolcratio ≥ 4.5

                144 (14.3)

                132 (12.7)

                276 (13.5)

                *: p < 0.01; **: p < 0.05. Values are expressed as Mean ± SD or numbers with percent in parentheses.

                Age-specific mean values of various clinical, anthropometric and biochemical characteristics are shown in Table 2. Both in males and females significantly increasing trend in BMI, WC, WHR, systolic BP, cholesterol, LDL cholesterol, triglycerides and a decreasing trend in HDL cholesterol levels is observed (regression analyses, p < 0.001). In both males and females there is a steep increase in mean BMI, WC, and WHR as these men move from age-groups 20–29 to 30–39 years. Similar increasing trends are observed in mean levels of total- and LDL cholesterol and triglycerides with declining trends in HDL cholesterol levels (Figure 1, p < 0.001). Age-related trends in the prevalence of various cardiovascular risk factors are presented in Table 3. In both men and women the prevalence of obesity is low in age groups 15–20 and 20–29 years with a steep increase in age-group 30–39 years (men 36.8%, women 52.1%) (Χ 2 test, p for trend < 0.001). Similar changes are observed in the prevalence of high WC and high WHR (p for trend < 0.001). A significantly increasing trend in prevalence of hypertension, impaired fasting glucose, high LDL cholesterol, hypertriglyceridemia, high total:HDL cholesterol ratio, low HDL cholesterol, diabetes and the metabolic syndrome is also observed.
                Table 2

                Cardiovascular Risk Factors at Different Age-Groups (Mean ± SD) and Trends

                Variables

                Males

                Females

                 

                15–19 years (n = 699)

                20–29 years (n = 175)

                30–39 years (n = 133)

                Regression coefficient, standardized beta, p-value

                15–19 years (n = 591)

                20–29 years (n = 311)

                30–39 years (n = 140)

                Regression coefficient, standardized beta, p-value

                Body mass index (kg/m2)

                19.7 ± 3.3

                21.5 ± 4.0

                24.1 ± 5.6

                2.11 ± 0.17,0.37, <0.001

                20.0 ± 3.2

                20.2 ± 3.3

                24.7 ± 5.1

                1.80 ± 0.16, 0.332, <0.001

                Waist circumference (cm)

                70.6 ± 9.2

                77.7 ± 10.8

                89.6 ± 14.0

                9.04 ± 0.45, 0.53, <0.001

                66.8 ± 7.7

                69.9 ± 9.1

                83.8 ± 11.8

                7.12 ± 0.39, 0.491, <0.001

                Waist-hip ratio

                0.81 ± 0.05

                0.85 ± 0.09

                0.91 ± 0.07

                0.047 ± 0.03, 0.48, <0.001

                0.75 ± 0.06

                0.78 ± 0.06

                0.84 ± 0.07

                0.04 ± 0.01, 0.457, <0.001

                Systolic blood pressure (mm Hg)

                115.0 ± 9.6

                118.2 ± 10.8

                117.3 ± 15.9

                1.56 ± 0.48, 0.10, 0.001

                111.0 ± 9.0

                110.4 ± 9.5

                114.5 ± 17.0

                1.16 ± 0.46, 0.078, 0.011

                Diastolic blood pressure (mm Hg)

                74.4 ± 7.2

                75.6 ± 8.2

                76.5 ± 11.9

                1.07 ± 0.36, 0.09, 0.003

                72.9 ± 6.9

                72.8 7.2

                75.0 ± 11.2

                0.74 ± 0.33, 0.069, 0.025

                Glucose fasting (mg/dl)

                90.0 ± 9.2

                86.7 ± 2.5

                94.1 ± 28.2

                1.02 ± 0.61, 0.05, 0.096

                88.7 ± 8.3

                87.7 ± 8.3

                88.4 ± 21.0

                -0.36 ± 0.47, -0.024, 0.441

                Total cholesterol (mg/dl)

                144.4 ± 26.0

                151.9 ± 38.9

                203.9 ± 47.6

                25.51 ± 1.5, 0.48, <0.001

                156.4 ± 23.0

                160.9 25.7

                193.0 ± 41.0

                14.81 ± 1.19, 0.361, <0.001

                LDL cholesterol (mg/dl)

                79.0 ± 25.9

                86.8 ± 2.5

                130.0 ± 40.9

                22.11 ± 1.4, 0.45, <0.001

                86.5 ± 24.3

                90.9 ± 26.7

                126.6 ± 38.0

                16.14 ± 1.21, 0.382, <0.001

                Triglycerides (mg/dl)

                87.5 ± 30.1

                104.3 ± 39.9

                173.5 ± 111.5

                37.99 ± 2.3, 0.47, <0.001

                92.7 ± 28.0

                88.2 ± 29.5

                137.3 ± 70.6

                15.54 ± 1.67, 0.277, <0.001

                HDL cholesterol (mg/dl)

                47.7 ± 6.8

                45.1 ± 7.9

                39.2 ± 9.0

                -3.94 ± 0.32, -0.36, <0.001

                51.1 ± 8.6

                52.6 ± 6.2

                39.0 ± 8.5

                -4.14 ± 0.40, -0.303, <0.001

                Total: HDL cholesterol ratio

                3.1 ± 0.70

                3.5 ± 1.4

                5.5 ± 2.1

                1.06 ± 0.05, 0.55, <0.001

                3.2 ± 0.73

                3.2 ± 0.85

                5.2 ± 1.72

                0.77 ± 0.045, 0.468, <0.001

                Table 3

                Prevalence of Various Cardiovascular Risk Factors at Different Age-Groups and Trends

                Variables

                Males

                Females

                 

                15–19 years (n = 699)

                20–29 years (n = 175)

                30–39 years (n = 133)

                X2 for trend (p-value)

                15–19 years (n = 591)

                20–29 years (n = 311)

                30–39 years (n = 140)

                X2 for trend (p-value)

                Body mass index ≥ 25 Kg/m2

                53 (7.6)

                20 (11.5)

                49 (36.8)

                89.85 (<0.001)

                52 (8.8)

                23 (7.4)

                73 (52.1)

                191.09 (<0.001)

                Body mass index ≥ 30 Kg/m2

                7 (1.0)

                7 (4.0)

                17 (12.8)

                52.55 (<0.001)

                5 (0.8)

                7 (2.3)

                22 (15.7)

                80.62 (<0.001)

                Waist circumference > 90 cm/80 cm

                32 (4.6)

                20 (11.4)

                67 (50.4)

                224.94 (<0.001)

                36 (6.1)

                31 (10.0)

                86 (61.4)

                284.55 (<0.001)

                Waist hip ratio > 0.9/0.8

                34 (4.9)

                33 (18.9)

                69 (51.9)

                216.64 (<0.001)

                85 (14.4)

                107 (34.4)

                104 (74.3)

                207.56 (<0.001)

                Hypertension

                16 (2.3)

                10 (5.7)

                31 (23.3)

                92.45 (<0.001)

                2 (0.3)

                5 (1.6)

                25 (17.9)

                119.89 (<0.001)

                Impaired fasting glucose (100–125 mg/dl)

                99 (14.2)

                10 (5.7)

                26 (19.5)

                13.59 (0.001)

                49 (8.3)

                20 (6.4)

                16 (11.4)

                3.25 (0.197)

                Diabetes mellitus (≥ 126 mg/dl)

                -

                1 (0.6)

                9 (6.8)

                52.43 (<0.001)

                -

                -

                4 (2.9)

                25.87 (<0.001)

                LDL cholesterol ≥ 130 mg/dl

                17 (2.4)

                24 (13.7)

                54 (40.6)

                195.08 (<0.001)

                19 (3.2)

                18 (5.8)

                55 (39.3)

                188.05 (<0.001)

                Triglycerides ≥ 150 mg/dl

                21 (3.0)

                18 (10.3)

                57 (42.9)

                205.92 (<0.001)

                19 (3.2)

                9 (2.9)

                35 (25.0)

                102.32 (<0.001)

                HDL cholesterol <40 mg/dl

                56 (8.0)

                30 (17.1)

                77 (57.9)

                205.09 (<0.001)

                268 (45.3)

                120 (38.6)

                129 (92.1)

                120.73 (<0.001)

                Total: HDL cholesterol ratio ≥ 4.5

                26 (3.7)

                30 (17.1)

                79 (59.4)

                300.95 (<0.001)

                28 (4.7)

                22 (7.1)

                82 (58.6)

                309.04 (<0.001)

                Metabolic syndrome

                -

                9 (5.1)

                26 (19.5)

                129.04 (<0.001)

                1 (0.2)

                3 (1.0)

                28 (20.0)

                156.14 (<0.001)

                Numbers in parentheses are percent.

                http://static-content.springer.com/image/art%3A10.1186%2F1471-2261-9-28/MediaObjects/12872_2009_Article_249_Fig1_HTML.jpg
                Figure 1

                Age-related escalation in mean levels of systolic BP, fasting glucose, total cholesterol, LDL cholesterol and triglycerides and decline in HDL cholesterol levels in males and females (p for trend < 0.01). Values of systolic BP are in mm Hg and the others in mg/dl. Bars and whiskers indicate mean and SEM values respectively.

                Regression analyses reveal that age is an important determinant of blood pressure as well as multiple biochemical factors (Table 4). BMI, WC as well as WHR are significantly positively related with systolic BP, total cholesterol, LDL cholesterol, and triglycerides and negatively with HDL cholesterol. Age-adjustment reveals that while BMI is a more important determinant of systolic BP, waist circumference and waist-hip ratio are more important for biochemical abnormalities. All the associations loose significance when adjusted for age, BMI and measures of truncal obesity (Table 4). Trends of risk factors change with age using univariate and multivariate odds ratios are shown in Table 5. At age 15–19 years the prevalence (%) of risk factors in males and females, respectively, was overweight/obesity in 7.6, 8.8; high WHR 4.9, 14.4; hypertension 2.3, 0.3; high LDL cholesterol 2.4, 3.2; high triglycerides 3.0, 3.2; low HDL cholesterol 8.0, 45.3; high total:HDL ratio 3.7, 4.7, diabetes 0.0 and metabolic syndrome in 0.0, 0.2 percent. In males and females, respectively, as compared to age group 15–19 years, ORs for risk factors at age groups 20–29 years are for smoking 5.3, 1.0; obesity 1.6, 0.8; truncal obesity 4.5, 3.1; hypertension 2.6, 4.8; high LDL cholesterol 6.4, 1.8; high triglycerides 3.7, 0.9; low HDL cholesterol 2.4, 0.8; high total:HDL cholesterol 1.6, 1.0; diabetes 4.0, 1.0; and the metabolic syndrome 37.7, 5.7 (Table 5). The escalation is highly significant at age 30–39 with ORs for smoking 16.0, 6.3; overweight 7.1, 11.3; truncal obesity 21.1, 17.2; hypertension 13.0, 64.0; high LDL cholesterol 27.4, 19.5; high triglycerides 24.2, 10.0; low HDL cholesterol 15.8, 14.1; high total:HDL cholesterol 37.9, 6.10; diabetes 50.7, 17.4; and metabolic syndrome 168.5, 146.2 (Figure 2, p < 0.01 for all parameters). Multivariate adjustment for BMI, waist size and WHR in men and women aged 30–39 years results in attenuation in ORs for hypertension and various lipid parameters but remain significant.
                http://static-content.springer.com/image/art%3A10.1186%2F1471-2261-9-28/MediaObjects/12872_2009_Article_249_Fig2_HTML.jpg
                Figure 2

                Trends of increase in prevalence of hypertension, high LDL cholesterol, high triglyceride (TG) levels, low HDL cholesterol and diabetes with age in males and females. Relative prevalence of risk factors at age-groups 15–19 (odds ratio = 1), 20–29 and 30–39 is shown. The increase is slow from age 15–19 to 20–29 years with an exponential increase at age-group 30–39 years (p < 0.001).

                Table 4

                Standardized Regression Coefficients for Association of Cardiovascular Risk Factors with Age and Different Measures of Obesity.

                 

                Age

                Body Mass Index

                Waist Circumference

                Waist Hip Ratio

                  

                Univariate

                Age-Adjusted

                Multivariate adjusted for age, waist, WHR

                Univariate

                Age-Adjusted

                Multivariate adjusted for age, body mass index, WHR

                Univariate

                Age-Adjusted

                Multivariate adjusted for age, body mass index, waist

                Age

                -

                0.394***

                -

                -

                0.536***

                -

                -

                0.417***

                -

                -

                Systolic BP

                0.092***

                0.311***

                0.375***

                0.145***

                0.335***

                0.402***

                0.207***

                0.261***

                0.269***

                0.099**

                Cholesterol

                0.468***

                0.283***

                0.117***

                -0.012

                0.340***

                0.125***

                0.236***

                0.192***

                -0.004

                -0.142***

                LDL cholesterol

                0.459***

                0.276***

                0.113***

                -0.018

                0.341***

                0.133***

                0.227***

                0.208***

                0.020

                -0.111***

                HDL cholesterol

                -0.337***

                -0.195***

                -0.073**

                0.094*

                -0.302***

                -0.171***

                -0.202***

                -0.275***

                -0.163***

                -0.069*

                Triglycerides

                0.414***

                0.246***

                0.098***

                -0.028

                0.325***

                0.144***

                0.183**

                0.240***

                0.081*

                -0.021

                Glucose Fasting

                0.038

                0.026

                0.013

                -0.073

                0.056*

                0.049

                0.127*

                0.044*

                0.034

                -0.020

                BP blood pressure; WHR waist hip ratio; * p < 0.01; ** p < 0.001; ** p < 0.001;

                Table 5

                Relative prevalence of various risk factors with increasing age in males and females presented as univariate and adjusted odds ratios and 95% confidence intervals

                Variables

                Age group

                Univariate odds ratios

                Adjusted for body mass index

                Adjusted for waist circumference

                Adjusted for waist hip ratio

                Males

                     

                Smoking

                15–19

                1.0

                1.0

                1.0

                1.0

                 

                20–29

                5.3 (3.6–7.0)

                --

                --

                --

                 

                30–39

                16.0 (10.5–21.5)

                --

                --

                --

                Body mass index ≥ 25 kg/m2

                15–19

                1.0

                --

                1.0

                1.0

                 

                20–29

                1.6 (0.9–2.7)

                --

                --

                --

                 

                30–39

                7.1 (4.5–11.2)

                --

                --

                --

                Waist:hip ratio > 0.9

                15–19

                1.0

                1.0

                --

                --

                 

                20–29

                4.5 (2.7–7.6)

                --

                --

                --

                 

                30–39

                21.1 (12.9–34.2)

                --

                --

                --

                Hypertension

                15–19

                1.0

                1.0

                1.0

                1.0

                 

                20–29

                2.6 (1.2–5.8)

                1.7 (0.7–3.9)

                1.1 (0.4–2.8)

                1.3 (0.5–3.2)

                 

                30–39

                13.0 (6.9–24.6)

                7.4 (3.7–14.8)

                3.4 (1.5–7.5)

                4.3 (1.9–9.5)

                LDL cholesterol ≥ 130 mg/dl

                15–19

                1.0

                1.0

                1.0

                1.0

                 

                20–29

                6.4 (3.3–12.2)

                5.9 (3.0–11.5)

                4.7 (2.4–9.4)

                5.4 (2.7–10.9)

                 

                30–39

                27.4 (15.2–49.6)

                22.2 (11.7–42.0)

                16.7 (8.2–34.1)

                20.1 (9.8–41.3)

                Triglycerides ≥ 150 mg/dl

                15–19

                1.0

                1.0

                1.0

                1.0

                 

                20–29

                3.7 (1.9–7.1)

                2.7 (1.4–5.4)

                2.4 (1.2–4.8)

                2.6 (1.3–5.1)

                 

                30–39

                24.2 (13.9–42.1)

                19.9 (10.9–36.1)

                15.8 (8.2–30.8)

                16.8 (8.6–32.6)

                HDL cholesterol < 40 mg/dl

                15–19

                1.0

                1.0

                1.0

                1.0

                 

                20–29

                2.4 (1.5–3.8)

                2.4 (1.5–3.9)

                1.9 (1.2–3.3)

                1.7 (1.0–2.9)

                 

                30–39

                15.8 (10.2–24.5)

                15.1 (9.3–24.7)

                12.9 (7.4–22.6)

                10.9 (6.4–18.9)

                Total: HDL cholesterol > 4.5

                15–19

                1.0

                1.0

                1.0

                1.0

                 

                20–29

                1.6 (1.4–1.9)

                1.5 (1.3–1.8)

                1.4 (1.1–1.7)

                1.4 (1.2–1.7)

                 

                30–39

                37.9 (22.5–63.9)

                32.7 (18.6–57.5)

                27.9 (14.8–52.4)

                26.8 (14.3–50.3)

                Diabetes

                15–19

                1.0

                1.0

                1.0

                1.0

                 

                20–29

                4.0 (0.3–64.5)

                4.2 (0.3–69.9)

                2.6 (1.0–72.3)

                2.4 (0.9–67.0)

                 

                30–39

                50.7 (6.4–403.4)

                27.8 (3.2–242.7)

                26.2 (1.9–365.8)

                19.9 (1.2–336.1)

                Metabolic syndrome

                15–19

                1.0

                1.0

                1.0

                1.0

                 

                20–29

                37.7 (4.8–298.2)

                20.7 (2.5–171.7)

                14.3 (1.6–128.4)

                17.3 (2.1–148.5)

                 

                30–39

                168.5 (22.8–1247.1)

                95.6 (12.3–741.5)

                62.9 (6.4–621.3)

                59.1 (6.2–568.1)

                Females

                     

                Smoking

                15–19

                1.0

                1.0

                1.0

                1.0

                 

                20–29

                1.0

                --

                --

                --

                 

                30–39

                6.3 (5.5–7.1)

                --

                --

                --

                Body mass index ≥ 25 kg/m2

                15–19

                1.0

                1.0

                1.0

                1.0

                 

                20–29

                0.8 (0.5–1.4)

                --

                --

                --

                 

                30–39

                11.3 (7.3–11.5)

                --

                --

                --

                Waist:hip ratio > 0.8

                15–19

                1.0

                1.0

                1.0

                1.0

                 

                20–29

                3.1 (2.2–4.3)

                --

                --

                --

                 

                30–39

                17.2 (11.0–26.8)

                --

                --

                --

                Hypertension

                15–19

                1.0

                1.0

                1.0

                1.0

                 

                20–29

                4.8 (0.9–24.9)

                4.5 (0.9–23.7)

                3.1 (0.6–16.6)

                3.2 (0.6–16.7)

                 

                30–39

                64.0 (14.9–73.9)

                18.2 (4.1–82.9)

                10.3 (2.0–52.0)

                39.1 (7.9–192.7

                LDL cholesterol ≥ 130 mg/dl

                15–19

                1.0

                1.0

                1.0

                1.0

                 

                20–29

                1.8 (0.9–3.6)

                1.8 (0.9–3.5)

                1.6 (0.8–3.2)

                1.9 (0.9–3.7)

                 

                30–39

                19.5 (11.0–34.4)

                18.2 (9.5–34.8)

                17.2 (8.1–36.7)

                19.5 (9.7–39.2)

                Triglycerides ≥ 150 mg/dl

                15–19

                1.0

                1.0

                1.0

                1.0

                 

                20–29

                0.9 (0.4–2.0)

                0.9 (0.4–2.0)

                0.8 (0.3–1.8)

                0.8 (0.4–1.9)

                 

                30–39

                10.0 (5.5–18.2)

                8.5 (4.3–16.6)

                7.0 (3.2–15.1)

                8.2 (4.0–16.8)

                HDL cholesterol < 40 mg/dl

                15–19

                1.0

                1.0

                1.0

                1.0

                 

                20–29

                0.8 (0.6–1.0)

                0.8 (0.6–1.0)

                0.7 (0.5–0.9)

                0.7 (0.6–1.1)

                 

                30–39

                14.1 (7.5–26.7)

                11.9 (6.1–23.2)

                10.6 (5.2–21.8)

                15.8 (7.8–32.0)

                Total: HDL cholesterol > 4.5

                15–19

                1.0

                1.0

                1.0

                1.0

                 

                20–29

                1.0 (0.9–1.2)

                1.0 (0.8–1.2)

                0.9 (0.8–1.1)

                0.9 (0.8–1.2)

                 

                30–39

                6.1 (4.5–8.2)

                5.9 (4.3–8.3)

                5.3 (3.7–7.6)

                5.8 (4.1–8.1)

                Diabetes

                15–19

                1.0

                1.0

                1.0

                1.0

                 

                20–29

                1.0

                1.0

                1.0

                1.0

                 

                30–39

                17.4 (1.9–156.5)

                17.0 (1.3–217.7)

                31.6 (0.6–1605.0)

                22.0 (1.0–474.5)

                Metabolic syndrome

                15–19

                1.0

                1.0

                1.0

                1.0

                 

                20–29

                5.7 (0.6–55.3)

                5.2 (0.5–51.1)

                2.2 (0.2–23.4)

                3.0 (0.3–31.0)

                 

                30–39

                146.2 (19.9–1027.9)

                75.1 (9.7–583.9)

                19.7 (2.5–155.3)

                48.8 (6.3–378.9)

                Discussion

                This study shows a low prevalence of multiple cardiovascular risk factors (smoking, hypertension, lipid abnormalities and diabetes) among adolescents in an Indian urban population. The prevalence of multiple risk factors increases at age-group 20–29 years with an exponential increase in age group 30–39 years. Increasing risk factors correlate with body mass index, waist circumference and waist-hip ratio. A rapid increase in risk factors in young adulthood identifies the target group for interventions.

                Wardle et al reported development of adiposity during adolescence in an ethnically and socioeconomically diverse sample of young people in Britain [28]. It was observed that prevalence of overweight and obesity was high in London school students and there were significant socioeconomic and ethnic inequalities with low socioeconomic status Blacks having the highest prevalence. It was concluded that overweight and obesity was well established by the age of 11 years and prevention efforts need to be targeted early. Obesity among children that tracks into adulthood has also been reported in studies from Europe and USA [516]. Gordon-Larsen et al studied five year obesity incidence in the transition period between adolescence and adulthood as part of US National Longitudinal Study of Adolescent Health [29]. It was observed that during the 5-yer transition period the obesity incidence was 12.7% and there was a significant increase in obesity from 10.9% at 18 years of age to 22.1% at young adulthood. Our study on the other hand shows that the transition using similar obesity definitions occurs slightly later than the western populations. Reddy et al studied industrial populations in different parts of India and reported risk factor trends from age groups 20–29 years to ≥60 years [30]. In both men and women there was a steep increase in overweight and central obesity at age-group 30–39 years associated with increase in hypertension and biochemical risk factors. Reasons for the increase in weight beyond 30 years of age could be multiple. Socioeconomic changes that occur at this age in men include financial independence, marriage, transition from an active to sedentary working lifestyle, dietary changes, and psychological changes related to material and social environment [31]. In predominantly home-bound women apart from these changes others include less physical activity with grown-up children, dietary indiscretion and changes material environment [32, 33]. We did not study these socioeconomic variables in the present study and hence cannot comment on their importance. Studies in emigrant South Asians to UK have reported similar risk factor trends [34] as in the present study and highlight importance of lifestyle in escalating cardiovascular risks. The INTERHEART study reported that multiple cardiovascular risks occurred at a younger age among South Asians which explained younger age of acute myocardial infarction in these subjects [35]. The present study also shows a younger age of escalation of multiple cardiovascular risk factors and is similar to these studies.

                Obesity is a proximate factor for increase in multiple metabolic abnormalities [36]. The present study also shows that development of obesity and central obesity is associated with simultaneous increase in many biological risk factors such as changes in blood pressure levels and glucose and lipid abnormalities. Similar findings have been reported from the Bogalusa Heart Study [6], NHANES [7], and CARDIA study [9] and many other North American and European studies [5]. The present study shows that the increase in risk factors in a North Indian urban population starts at about the age of 30 years and focus of prevention should be at subjects lower than this age.

                Several limitations of the present study have to be highlighted. The sample survey for the adults was a population based data collection while for adolescents a school-based survey was performed. This would have excluded the very poor and illiterate children from the study in children in spite of inclusion of illiterates in the adult groups. There is a steep increase in BMI in the age groups ≥30 years in both men and women and inclusion of more poor children with low BMI would have enhanced the already steep change in BMI with increasing age. Secondly, the sample size at different age-groups is not similar and this could have resulted in a bias. However, this is a limitation of population-based study and can be overcome by using purposive age-stratified sampling which was not the design of the present study. Thirdly, this is analysis of cross-sectional data while an ideal study to observe age-related tracking of risk factors involves a prospective design [37]. Prospective studies are expensive and time-consuming and cross-sectional studies such as this are hypothesis generating and most of the time similar conclusions are reached. Fourthly, we used adult BMI criteria for defining overweight and obesity in subjects less than 18 years of age although the criteria are applicable to adults only. However, criteria of >95th percentile for obesity in adolescents are widely debated [29] and for sake of comparability our approach is justified. And finally, multiple ways to analyze secular data are available often involving complex statistics. As the present study was cross-sectional in nature we did not use such analyses.

                Conclusion

                India and many developing countries suffer from the double burden of under nutrition and over nutrition [38]. There is an urgent need to improve maternal and childhood nutrition to prevent fetal and childhood stunting and malnutrition related diseases. On the other hand, there is sufficient evidence that problems of under nutrition have been replaced by over nutrition in urban adults in these countries [39]. The crucial issue is age at which screening and intervention strategies should be initiated [40]. The present study shows that dietary and lifestyle changes to prevent adiposity and obesity and consequent epidemic of cardiovascular diseases in India and other such countries can be prevented by targeting men and women at age of about 30 years. A multi-factorial risk screening and intervention approach [41] at the population level could provide immediate benefit.

                Declarations

                Authors’ Affiliations

                (1)
                Department of Medicine, Fortis Escorts Hospital
                (2)
                Department of Diabetes and Metabolic Diseases, Fortis Rajan Dhall Hospital
                (3)
                Department of Medicine, All India Institute of Medical Sciences
                (4)
                Department of Biostatistics, All India Institute of Medical Sciences
                (5)
                Department of Home Science, University of Rajasthan

                References

                1. Beaglehole R, Yach D: Globalisation and the prevention and control of non-communicable disease: the neglected chronic diseases of adults. Lancet 2003, 362:903–908.View ArticlePubMed
                2. Reddy KS: Cardiovascular diseases in non-western countries. N Engl J Med 2004, 350:2438–2440.View ArticlePubMed
                3. Yusuf S, Reddy KS, Ounpuu S, Anand S: Global burden of cardiovascular diseases. Part I: general considerations, the epidemiological transition, risk factors and impact of urbanization. Circulation 2001, 104:2746–2753.View ArticlePubMed
                4. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al.: Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (The INTERHEART Study): Case control study. Lancet 2004, 364:937–952.View ArticlePubMed
                5. Davidson DM: Children and adolescents. Preventive Cardiology 2 Edition (Edited by: Wong ND, Black HR, Gardin JM). New York. McGraw Hill 2005, 357–383.
                6. Srinivasan SR, Bao W, Wattigney WA, Berenson GS: Adolescent overweight is associated with adult overweight and related multiple cardiovascular risk factors: the Bogalusa Heart Study. Metab Clin Exp 1996, 45:235–240.PubMed
                7. Ogden CL, Flegal KM, Carroll MD, Johnson CL: Prevalence and trends in overweight among US children and adolescents. JAMA 2002, 288:1728–1732.View ArticlePubMed
                8. Davis PH, Dawson JD, Mahoney LT, Lauer RM: Increased carotid intimal-medial thickness and coronary calcification are related in young and middle-aged adults. The Muscatine study. Circulation 1999, 100:838–842.PubMed
                9. Bild DE, Folsom AR, Lowe LP, Sidney S, Kiefe C, Westfall AO, et al.: Prevalence and correlates of coronary calcification in black and white young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arterioscler Thromb Vasc Biol 2001,21(5):852–857.PubMed
                10. Oren A, Vos LE, Uiterwaal CS, Grobbee DE, Bots ML: Cardiovascular risk factors and increased carotid intima-media thickness in healthy young adults: the Atherosclerosis Risk in Young Adults (ARYA) Study. Arch Intern Med 2003, 163:1787–1792.View ArticlePubMed
                11. Knoflach M, Kiechl S, Kind M, Said M, Sief R, Gisinger M, et al.: Cardiovascular risk factors and atherosclerosis in young males: ARMY study (Atherosclerosis Risk-Factors in Male Youngsters). Circulation 2003, 108:1064–1069.View ArticlePubMed
                12. Zieske AW, Malcom GT, Strong JP: Natural history and risk factors of atherosclerosis in children and youth: the PDAY study. Pediatr Pathol Mol Med 2002, 21:213–237.View ArticlePubMed
                13. Sinaiko AR, Donahue RP, Jacobs DR, Prineas RJ: Relation of weight and rate of increase in weight during childhood and adolescence to body size, blood pressure, fasting insulin, and lipids in young adults. The Minneapolis Children's Blood Pressure Study. Circulation 1999, 99:1471–1476.PubMed
                14. Juonala M, Viikari JS, Hutri-Kahonen N, Pietikainen M, Jokinen E, Taittonen L, et al.: The 21-year follow-up of the Cardiovascular Risk in Young Finns Study: risk factor levels, secular trends and east-west difference. J Intern Med 2004, 255:457–468.View ArticlePubMed
                15. Boreham C, Twisk J, Neville C, Savage M, Murray L, Gallagher A: Associations between physical fitness and activity patterns during adolescence and cardiovascular risk factors in young adulthood: the Northern Ireland Young Hearts Project. Int J Sports Med 2002,23(Suppl 1):S22–26.View ArticlePubMed
                16. McCarthy HD, Jarrett KV, Emmett PM, Rogers I: Trends in waist circumference in young British children. Int J Obesity 2005, 29:157–162.View Article
                17. Parsons TJ, Power C, Logan S, Summerbell CD: Childhood predictors of adult obesity: a systematic review. Int J Obes Relat Metab Disord 1999, 23 Suppl 8:S1-S107.PubMed
                18. Tuzcu EM, Kapadia SR, Tutal E, Ziada KM, Hobbs RE, McCarthy PM, et al.: High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults. Circulation 2001, 103:2705–2710.PubMed
                19. Lloyd-Jones DM, Leip EP, Larson MG, D'Agostino RB, Beiser A, Wilson PWF, et al.: Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 2006, 113:791–798.View ArticlePubMed
                20. Gupta R, Goyle A, Kashyap S, Agarwal M, Consul R, Jain BK: Prevalence of atherosclerosis risk factors in adolescent school children. Indian Heart J 1998, 50:511–515.PubMed
                21. Vikram NK, Misra A, Dwivedi M, Sharma R, Pandey RM, Luthra K, et al.: Correlations of C-reactive protein levels with anthropometric profile, percentage of body fat and lipids in healthy adolescents and young adults in urban North India. Atherosclerosis 2003, 168:305–313.View ArticlePubMed
                22. Sachdev HPS: Recent transitions in anthropometric profile of Indian children: clinical and public health implications. NFI Bull 2003,24(2):6–8.
                23. Gupta R, Rastogi P, Arora S: Low obesity and high undernutrition prevalence in lower socioeconomic status school girls: a double jeopardy. Human Ecology 2006, 14:120–132.
                24. Misra A, Vikram NK, Arya S, Pandey RM, Dhingra V, Chatterjee A, et al.: High prevalence of insulin resistance in postpubertal Asian Indian children is associated with adverse truncal body fat patterning, abdominal obesity and excess body fat. Int J Obesity 2004, 28:1217–1226.View Article
                25. Gupta R, Gupta VP, Sarna M, Bhatnagar S, Thanvi J, Sharma V, et al.: Prevalence of coronary heart disease and risk factors in an urban Indian population: Jaipur Heart Watch-2. Indian Heart J 2002, 54:59–66.PubMed
                26. National Cholesterol Education Program: Third report of the national cholesterol education program expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Circulation 2002, 106:3143–3421.
                27. Misra A, Vikram NK, Gupta R, Pandey RM, Wasir JS, Gupta VP: Waist circumference cutoff points and action levels for Asian Indians for identification of abdominal obesity. Int J Obesity 2006, 30:106–111.View Article
                28. Wardle J, Brodersen NH, Cole TJ, Jarvis MJ, Boniface DR: Development of adiposity in adolescence: five year longitudinal study of an ethnically and socioeconomically diverse sample of young people in Britain. BMJ 2006, 332:1130–1132.View ArticlePubMed
                29. Gordon-Larsen P, Adair LS, Nelson MC, Popkin BM: Five year obesity incidence in the transition period between adolescence and adulthood: the National Longitudinal Study of Adolescent Health. Am J Clin Nutr 2004, 80:569–575.PubMed
                30. Reddy KS, Prabhakaran D, Chaturvedi V, Jeemon P, Thankappan KR, Ramakrishnan L, et al.: Methods for establishing a surveillance system for cardiovascular diseases in Indian industrial populations. Bull WHO 2006, 84:461–469.PubMed
                31. Marmot M: Multilevel approaches to understanding social determinants. Social epidemiology (Edited by: Berkman LF, Kawachi I). Oxford. Oxford University Press 2000, 349–367.
                32. Vatsyayan DR: Status of women in Hindu society. Indian Society and Social Institutions 5 Edition Meerut, India. Kedarnath Ramnath Publishers 1978, 75–81.
                33. Gupta R, Misra A, Pais P, Rastogi P, Gupta VP: Correlation of regional cardiovascular disease mortality in India with lifestyle and nutritional factors. Int J Cardiol 2006, 108:291–300.View ArticlePubMed
                34. Patel JV, Vyas A, Cruickshank JK, Prabhakaran D, Hughes E, Reddy KS, et al.: Impact of migration on coronary heart disease risk factors: comparison of Gujaratis in Britain and their contemporaries of villages of origin in India. Atherosclerosis 2006, 185:297–306.View ArticlePubMed
                35. Joshi PP, Islam S, Pais P, Reddy KS, Prabhakaran D, Kazmi K, et al.: Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA 2007, 297:286–294.View ArticlePubMed
                36. McCowen KC, Blackburn GL: Obesity and weight control. Preventive Cardiology 2 Edition (Edited by: Wong ND, Black HR, Gardin JM). New York. McGraw Hill 2005, 357–383.
                37. Lynch J, Davey-Smith G: A life course approach to chronic disease epidemiology. Annu Rev Public Health 2005, 26:1–35.View ArticlePubMed
                38. Reddy KS, Shah B, Varghese C, Ramadoss A: Responding to the threat of chronic diseases in India. Lancet 2005, 336:1744–1749.
                39. Gupta R, Joshi PP, Mohan V, Reddy KS, Yusuf S: Epidemiology and causation of coronary heart disease and stroke in India. Heart 2008, 94:16–26.View ArticlePubMed
                40. Schiffman M, Wacholder S: From India to the world: a better way to prevent cervical cancer. N Engl J Med 2009, 360:1453–1455.View ArticlePubMed
                41. Ezzati M, Hoorn SV, Rodgers A, Lopez AD, Mathers CD, Murray CJL: Estimates of global and regional potential health gains from reducing multiple risk factors. Lancet 2003, 362:271–280.View ArticlePubMed
                42. Pre-publication history

                  1. The pre-publication history for this paper can be accessed here:http://​www.​biomedcentral.​com/​1471-2261/​9/​28/​prepub

                Copyright

                © Gupta et al. 2009

                This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.